Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer

Author(s): Atefeh Arab, Rezvan Yazdian Robati, Jessica Nicastro, Roderick Slavcev and Javad Behravan*

Volume 24 , Issue 11 , 2018

Page: [1195 - 1203] Pages: 9

DOI: 10.2174/1381612824666180327152117

Price: $65


Despite years of investigation, breast cancer remains a major cause of death worldwide. Phage display is a powerful molecular method in which peptide and protein libraries can be displayed via genetic fusions on the surface of phages. This approach has tremendous potential for biomedical applications and has already facilitated the discovery of specific antibodies, specific antigens, and peptides with potential roles in the diagnosis and treatment of malignancies including breast cancer. In this review, we discuss the new and the latest advancements in the applications of the phage display technique in the provision of immune therapeutics for breast cancer.

Keywords: Bacteriophage, phage display, breast cancer, immune therapeutics, peptide library, vaccine.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy